Gotham Asset Management’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Gotham Asset Management’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-210,936	Closed	-$2.62M	–	1183
2016 Q4	$2.62M	Buy	210,936 +56,049	+36%	+$675K	0.03%	472
2016 Q3	$2.12M	Buy	+154,887	New	+$1.56M	0.03%	486
2015 Q2	–	Sell	-16,344	Closed	-$135K	–	1114
2015 Q1	$135K	Buy	+16,344	New	+$121K	﹤0.01%	875

Other funds holding ARIA

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Gotham Asset Management's ARIA Position: Q1 2017 in Review

Gotham Asset Management sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 210,936 shares — an estimated $2.62M sold.

Gotham Asset Management first reported a position in ARIA in Q1 2015 and held it in 3 quarters. The position peaked at $2.62M in Q4 2016. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

Gotham Asset Management reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
Gotham Asset Management sold 210,936 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $2.62M.
Gotham Asset Management first reported a position in Ariad Pharmaceuticals Inc in Q1 2015 and held it in 3 quarters.
Gotham Asset Management's Ariad Pharmaceuticals Inc position peaked at $2.62M in Q4 2016.
1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Gotham Asset Management's 13F filing for Q1 2017, filed 15 May 2017.